The Accounts Companies House intelligence

OXOID (ELY) LIMITED

#02183692 · Active · Incorporated 1987-10-26 (38y 7m) · Last filing 2026-04-01 (1mo ago)
Industrials · SIC 74990 · M Professional, Scientific & Technical Activities · Full accounts

Get an alert when OXOID (ELY) LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-01-14 (in 8mo)

Last made up 2025-12-31

Watchouts

None on the register

Cash

—

Latest balance sheet

Net assets

-£1M

+19% vs 2023

Employees

0

Average over period

Profit before tax

£328K

+8.3% vs 2023

Name history

Renamed 6 times since incorporation

  1. OXOID (ELY) LIMITED 2006-09-13 → present
  2. DAKOCYTOMATION LIMITED 2002-07-01 → 2006-09-13
  3. DAKO LIMITED 1997-08-01 → 2002-07-01
  4. DAKO DIAGNOSTICS LIMITED 1991-11-01 → 1997-08-01
  5. NOVO NORDISK DIAGNOSTICS LIMITED 1990-01-01 → 1991-11-01
  6. NOVO BIOLABS LIMITED 1987-12-16 → 1990-01-01
  7. NICEVITAL LIMITED 1987-10-26 → 1987-12-16

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £6,000£5,000
Operating profit -£9,000-£15,000
Profit before tax £303,000£328,000
Net profit £303,000£304,000
Cash ——
Total assets less current liabilities -£1,598,000-£1,294,000
Net assets -£1,598,000-£1,294,000
Equity -£1,598,000-£1,294,000
Average employees 00
Wages ——

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin -150.0%-300.0%
Net margin 5050.0%6080.0%
Return on capital employed 0.6%1.2%
Current ratio 0.87x0.90x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
Mitchell Charlesworth (Audit) Limited
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“Thermo Fisher Scientific Inc. has indicated its intention to provide any necessary financial support to enable the company to continue in operational existence for the foreseeable future. To this extent, the directors have received a letter of support from Thermo Fisher Scientific Inc. confirming their financial support for a period of at least twelve months from when these financial statements are authorised for issue. Thus, the directors believe that it is appropriate for the financial statements to be prepared on the going concern basis.”

Group structure

  1. OXOID (ELY) LIMITED · parent
    1. Doublecape Limited 100% · United Kingdom

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

6 active · 31 resigned

Name Role Appointed Born Nationality
OAKWOOD CORPORATE SECRETARY LIMITED Corporate Secretary 2009-11-01 — —
AHMED, Syed Waqas Director 2020-03-23 Nov 1979 British
CAMERON, Euan Daney Ross Director 2018-10-31 Mar 1976 British
GREEN, Georgina Adams Director 2024-04-18 Mar 1970 British
SMITH, Anthony Hugh Director 2018-11-12 May 1962 American
STARR, Alison Jane Director 2024-04-18 Jan 1977 British
Show 31 resigned officers
Name Role Appointed Resigned
GREGG, Rhona Secretary 2015-09-10 2026-03-31
TATTAM, Charles Soren Robert Secretary — 2006-08-31
WARD, Nicola Jane Secretary 2007-02-08 2014-12-18
WHITELEY, Raymond Robert Secretary 2006-08-31 2007-02-08
A G SECRETARIAL LIMITED Corporate Secretary 2007-02-01 2009-10-31
COLEY, James Robert Ewen Director 2006-11-09 2012-04-18
DINESEN, Vagn Aage Director — 1997-06-29
GODTFREDSEN, Sven Erik Director 1994-09-15 1997-07-01
GORST, Jeanette Director 1997-07-04 2000-12-15
GOWER, Geoffrey James Director 1992-07-01 2007-02-26
GRANT, Lucie Mary Katja Director 2013-02-07 2019-12-03
HUEG, Kim Arthur Director — 1994-09-14
INCE, Nicholas Director 2015-09-10 2018-10-31
JOHANNSSON, Axel, Dr Director 1992-07-01 2004-05-31
JOHANNSSON, Bengt Gosta Director — 1994-09-15
JORGENSEN, Torben Vedel Stahl Director — 1999-06-29
KRISTENSEN, Peder Joern Director 1995-09-14 1997-06-27
MADDEN, Christopher John Frank Director 1994-09-15 1997-06-27
MCCONNELL, Sarah Hlavinka Director 2006-08-18 2006-11-09
MEHTA, Chetan Praful Director 2006-08-18 2006-11-09
MOODIE, Iain Alasdair Keith Director 2012-04-18 2013-02-07
NORGAARD, Leif Director 2006-02-23 2006-08-31
NORMAN, David John Director 2015-11-16 2024-04-18
OSTERGAARD, Jes Christian Wibroe Director 1999-08-27 2005-12-21
SCHOFIELD, Kenneth Frank Director 1997-07-04 2004-04-30
SCRIVEN, John Richard Director — 1997-06-29
VABO, Bent Bors Director — 1992-07-27
WHEELER, Kevin Neil Director 2007-02-26 2015-11-16
WHITE, Sylvia Director 2006-11-09 2007-10-01
WINTHER, Erik Kofod Director 2005-12-21 2006-02-23
WRIGHT, Katie Rose Director 2010-12-01 2015-09-04

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
I Q (Bio) Limited Corporate entity Shares 75–100%, Voting 75–100%, Appoints directors 2016-04-06 Active

Filing timeline

Last 20 of 237 total filings

Date Type Category Description
2026-04-01 TM02 officers Termination secretary company with name termination date PDF
2026-01-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2025-07-02 AA accounts Accounts with accounts type full
2025-01-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-10-11 AA accounts Accounts with accounts type full
2024-04-23 AP01 officers Appoint person director company with name date PDF
2024-04-19 AP01 officers Appoint person director company with name date PDF
2024-04-19 TM01 officers Termination director company with name termination date PDF
2024-01-02 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-06-12 AA accounts Accounts with accounts type small
2023-01-04 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-04-08 AA accounts Accounts with accounts type small
2022-01-07 CS01 confirmation-statement Confirmation statement with no updates PDF
2021-04-20 AA accounts Accounts with accounts type small
2021-01-04 CS01 confirmation-statement Confirmation statement with updates PDF
2020-05-18 AA accounts Accounts with accounts type small
2020-03-24 AP01 officers Appoint person director company with name date PDF
2019-12-31 CS01 confirmation-statement Confirmation statement with no updates PDF
2019-12-10 TM01 officers Termination director company with name termination date PDF
2019-04-18 AA accounts Accounts with accounts type full

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
3

last 12 months

Capital events
0

last 24 months

Officers appointed
0

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page